"ltr">The company of Danish origin reported that " ...In January 2019, Coloplast will start operating in a temporary location, located next to what will be its new manufacturing plant. This will create the organizational bases for future expansion and let us get to know the local business environment."

See "Central America: $252 million in industrial plants"

From statement issued by Coloplast:

May 15, 2018. Coloplast is expanding its operation with a new manufacturing plant in Cartago, Costa Rica  

Coloplast is a global leader in products for ostomy and continence, and is one of the best performaning medical device companies in the world, growing at twice the speed of the market. Growth in demand for devices requires greater production capacity.  

"Coloplast is a leader in the global market and it is our goal to continue gaining market share. Therefore, we need to expand our global manufacturing footprint and we have chosen Costa Rica as the perfect place to set up our new manufacturing plant. In addition to increasing our global manufacturing capacity, we can support the significant future growth of the Americas market," said Coloplast's executive vice president of global operations, Allan Rasmussen.  

In January 2019, Coloplast will start operating in a temporary location, located next to what will be its new manufacturing plant.  This will create the organizational bases for future expansion and it will let us get to know the local business environment. During the first two years, Coloplast expects to employ approximately 100 workers.   

Read full release (in Spanish).

Do you need more information about your business sector?

Request more information:

Your message has been sent. We will contact you shortly.

Name*

Last Name*

Email:*

Telephone (Country):*

Company:*

Title:*

Size of the Company:* Choose one... Less than 50 employees Between 50 and 250 More than 250

You want to be called by an advisor?*

Comments:*  

this site is protected by reCAPTCHA and Google's privacy policy and terms of service.

Need assistance? Contact us

(506) 4001-6423

More on this topic

Medical Device Plant Investment

October 2018

The medical device manufacturer Precision Concepts Medical Technologies will invest $5 million in the construction and operation of a new plant in Costa Rica.

According to the Costa Rican Coalition of Development Initiatives (Cinde), the health sector company's investment will focus on the construction of a building and the implementation of state-of-the-art technology.

Specialized Manufacturing Plant Expanded

February 2018

With a $15 million investment, the US company Microtechnologies has expanded its specialized device production plant located in Coyol de Alajuela, Costa Rica.

The company specializes in the design and manufacture of critical miniature components that change the market through its use in platforms such as engine management systems, invasive surgical devices and safety controls for occupants. 

Costa Rica: Medical Device Plant Inaugurated

October 2016

With an investment of $55 million the global company Smith and Nephew has started operating a new plant in Alajuela for manufacturing orthopedic devices.

From a press release issued by Smith Nephew:

British company expands operations in Costa Rica and expects to create up to 250 additional jobs for the next two years. 

Costa Rica: More Investment in Medical Devices

January 2015

An announcement has been made that the company Apollo Endosurgery is to set up a 1750 meter device manufacturing plant in the Coyol area in the province of Alajuela.

From a statement issued by the Costa Rican Coalition for Development Initiatives (CINDE):

Apollo Endosurgery, Inc., a US medical device company, today announced that it has chosen Costa Rica as a site to install its new manufacturing plant in Coyol, Alajuela, where it will develop a variety of products including LAP-BAND® System - the only device approved by the FDA for weight reduction in people with at least one health problem related to obesity and who have a Body Mass Index of 30 or more.